Načítá se...
Intravitreal bevacizumab upregulates transthyretin in experimental branch retinal vein occlusion
PURPOSE: To identify retinal protein changes that mediate beneficial effects of intravitreal bevacizumab in experimental branch retinal vein occlusion (BRVO). METHODS: In six Danish Landrace pigs, BRVO was induced with argon laser in both eyes. After BRVO was induced, the right eye of each animal wa...
Uloženo v:
| Vydáno v: | Mol Vis |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Molecular Vision
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6279196/ https://ncbi.nlm.nih.gov/pubmed/30581282 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|